====== Coronavirus Immunotherapy Consortium ======

{{ ::cropped-covic-logo-2.png?200|}}

The **Coronavirus Immunotherapy Consortium (CoVIC)** is a global public-private partnership based out of the [[Center for Infectious Disease and Vaccine Research]] at the [[La Jolla Institute for Immunology]].((//Contact.// Coronavirus Immunotherapy Consortium. Retrieved January 19, 2023, from https://web.archive.org/web/20230119213903/https://covic.lji.org/contact/)) CoVIC's principal investigator is [[Erica Saphire]].

The stated purpose of the consortium is to "accelerate discovery, optimization, and delivery of life-saving [[antibody-based therapeutics]] against [[SARS-CoV-2]]."((//About CoVIC.// Coronavirus Immunotherapy Consortium. Retrieved January 19, 2023, from https://web.archive.org/web/20230119213917/https://covic.lji.org/about/))

===== History =====

CoVIC is a continuation of the [[Viral Hemorrhagic Fever Immunotherapeutic Consortium]] (VIC), which was previously formed to collect donations of antibodies against [[Ebola]] and [[Lassa]] viruses.((//CoVIC Formation and Mission.// Coronavirus Immunotherapy Consortium. Retrieved January 19, 2023, from https://archive.ph/9XgOh))

===== Organization =====

==== Partners ====

Consortium partners include:((//Partners.// Coronavirus Immunotherapy Consortium. Retrieved January 19, 2023, from https://archive.ph/gsq0B))

  * [[Carterra]]
  * [[Duke University]]
  * [[La Jolla Institute for Immunology]]
  * [[pharmaceutical_companies:Nexelis]]
  * [[Texas Biomedical Research Institute]]
  * [[University of Texas Medical Branch]]
  * [[University of Wisconsin-Madison]]

==== Funding ====

CoVIC is funded by the [[COVID-19 Therapeutics Accelerator]], [[GHR Foundation]] and the [[National Institute of Allergy and Infectious Diseases]] (NIAID).((//About CoVIC.// Coronavirus Immunotherapy Consortium. Retrieved January 19, 2023, from https://web.archive.org/web/20230119213917/https://covic.lji.org/about/)) NIAID funding came as a supplement to a [[Center For Excellence in Therapeutic Research]] (CETR) to Dr. Saphire (U19 142790-02S1).

===== External links =====

  * [[https://wiki.whiteroseintelligence.com/en/Coronavirus-Immunotherapy-Consortium|White Rose Wiki]]